These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33025093)

  • 1. Optimal
    Draulans C; De Roover R; van der Heide UA; Kerkmeijer L; Smeenk RJ; Pos F; Vogel WV; Nagarajah J; Janssen M; Isebaert S; Maes F; Mai C; Oyen R; Joniau S; Kunze-Busch M; Goffin K; Haustermans K
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1211-1218. PubMed ID: 33025093
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Draulans C; Pos F; Smeenk RJ; Kerkmeijer L; Vogel WV; Nagarajah J; Janssen M; Mai C; Heijmink S; van der Leest M; Zámecnik P; Oyen R; Isebaert S; Maes F; Joniau S; Kunze-Busch M; De Roover R; Defraene G; van der Heide UA; Goffin K; Haustermans K
    Pract Radiat Oncol; 2021; 11(3):202-211. PubMed ID: 33941347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Bettermann AS; Zamboglou C; Kiefer S; Jilg CA; Spohn S; Kranz-Rudolph J; Fassbender TF; Bronsert P; Nicolay NH; Gratzke C; Bock M; Ruf J; Benndorf M; Grosu AL
    Radiother Oncol; 2019 Dec; 141():214-219. PubMed ID: 31431366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of
    Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
    Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer GTV delineation with biparametric MRI and
    Hearn N; Blazak J; Vivian P; Vignarajah D; Cahill K; Atwell D; Lagopoulos J; Min M
    Br J Radiol; 2021 Mar; 94(1119):20201174. PubMed ID: 33507812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraindividual comparison between
    Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference.
    Zamboglou C; Fassbender TF; Steffan L; Schiller F; Fechter T; Carles M; Kiefer S; Rischke HC; Reichel K; Schmidt-Hegemann NS; Ilhan H; Chirindel AF; Nicolas G; Henkenberens C; Derlin T; Bronsert P; Mavroidis P; Chen RC; Meyer PT; Ruf J; Grosu AL
    Radiother Oncol; 2019 Dec; 141():208-213. PubMed ID: 31431386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Manual and Semi-Automatic [
    Spohn SKB; Kramer M; Kiefer S; Bronsert P; Sigle A; Schultze-Seemann W; Jilg CA; Sprave T; Ceci L; Fassbender TF; Nicolay NH; Ruf J; Grosu AL; Zamboglou C
    Front Oncol; 2020; 10():600690. PubMed ID: 33365271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
    Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.
    Holzschuh JC; Mix M; Ruf J; Hölscher T; Kotzerke J; Vrachimis A; Doolan P; Ilhan H; Marinescu IM; Spohn SKB; Fechter T; Kuhn D; Bronsert P; Gratzke C; Grosu R; Kamran SC; Heidari P; Ng TSC; Könik A; Grosu AL; Zamboglou C
    Radiother Oncol; 2023 Nov; 188():109774. PubMed ID: 37394103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of
    Walacides D; Meier A; Knöchelmann AC; Meinecke D; Derlin T; Bengel FM; Ross TL; Wester HJ; Derlin K; Kuczyk MA; von Klot CAJ; Christiansen H; Henkenberens C
    Strahlenther Onkol; 2019 May; 195(5):420-429. PubMed ID: 30610354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
    Kostyszyn D; Fechter T; Bartl N; Grosu AL; Gratzke C; Sigle A; Mix M; Ruf J; Fassbender TF; Kiefer S; Bettermann AS; Nicolay NH; Spohn S; Kramer MU; Bronsert P; Guo H; Qiu X; Wang F; Henkenberens C; Werner RA; Baltas D; Meyer PT; Derlin T; Chen M; Zamboglou C
    J Nucl Med; 2021 Jun; 62(6):823-828. PubMed ID: 33127624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gross tumor volume delineation in primary prostate cancer on
    Zhang YN; Lu ZG; Wang SD; Lu X; Zhu LL; Yang X; Fu LP; Zhao J; Wang HF; Xiang ZL
    Cancer Imaging; 2022 Jul; 22(1):36. PubMed ID: 35869521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer.
    Zarei M; Wallsten E; Grefve J; Söderkvist K; Gunnlaugsson A; Sandgren K; Jonsson J; Keeratijarut Lindberg A; Nilsson E; Bergh A; Zackrisson B; Moreau M; Thellenberg Karlsson C; Olsson LE; Widmark A; Riklund K; Blomqvist L; Berg Loegager V; Axelsson J; Strandberg SN; Nyholm T
    Acta Oncol; 2024 Jun; 63():503-510. PubMed ID: 38912830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-Head Comparison of
    Kuten J; Fahoum I; Savin Z; Shamni O; Gitstein G; Hershkovitz D; Mabjeesh NJ; Yossepowitch O; Mishani E; Even-Sapir E
    J Nucl Med; 2020 Apr; 61(4):527-532. PubMed ID: 31562225
    [No Abstract]   [Full Text] [Related]  

  • 17. 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer.
    Fendler WP; Schmidt DF; Wenter V; Thierfelder KM; Zach C; Stief C; Bartenstein P; Kirchner T; Gildehaus FJ; Gratzke C; Faber C
    J Nucl Med; 2016 Nov; 57(11):1720-1725. PubMed ID: 27261520
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal dose escalation for prostate cancer using
    Zamboglou C; Thomann B; Koubar K; Bronsert P; Krauss T; Rischke HC; Sachpazidis I; Drendel V; Salman N; Reichel K; Jilg CA; Werner M; Meyer PT; Bock M; Baltas D; Grosu AL
    Radiat Oncol; 2018 May; 13(1):81. PubMed ID: 29716617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison.
    Zamboglou C; Schiller F; Fechter T; Wieser G; Jilg CA; Chirindel A; Salman N; Drendel V; Werner M; Mix M; Meyer PT; Grosu AL
    Theranostics; 2016; 6(10):1619-28. PubMed ID: 27446496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.